| Oct 16 |
Abbott Laboratories' Q3 Earnings: Revenue And EPS Beat, Company Says Well-Positioned To Achieve Upper End Of Annual Forecast
|
| Oct 16 |
Abbott (ABT) Q3 Earnings and Revenues Surpass Estimates
|
| Oct 16 |
Abbott raises earnings outlook as MedTech, Pharma drive Q3 beat
|
| Oct 16 |
Abbott in charts: Medical Devices sales sustain double-digit Y/Y growth with an 11.7% rise in Q3
|
| Oct 16 |
Earnings Snapshot: Abbott Laboratories beats consensus in Q3, tightens FY2024 outlook
|
| Oct 16 |
Abbott: Q3 Earnings Snapshot
|
| Oct 16 |
Abbott slightly raises profit forecast on strong medical device sales
|
| Oct 16 |
Abbott Laboratories Non-GAAP EPS of $1.21 beats by $0.01, revenue of $10.64B beats by $90M
|
| Oct 16 |
Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range
|
| Oct 16 |
US Stocks Could Open Narrowly Mixed After Tuesday's Chip Sell-Off, Bitcoin Heads To $68K, Oil Slips
|
